ADARx Pharmaceuticals Plans IPO of 21.9M Shares at $15-$17 Each

09:25 AM EDT, 09/21/2026 (MT Newswires) -- ADARx Pharmaceuticals (ADRX) plans to offer 21.9 million shares of common stock in an initial public offering expected to be priced at $15 to $17 per share, the company said in a Monday filing. The offering includes a 30-day option for underwriters to purchase up to an additional 3.281 million shares. The company has applied to list its shares on the Nasdaq Global Select Market under the symbol "ADRX," with the offering contingent on approval of the listing. Separately, AbbVie (ABBV) will purchase shares in a concurrent private placement, targeting a 4.9% stake in ADARx, capped at $100 million, with the deal closing alongside the IPO.